|The measurement and clinical relevance of brain atrophy in multiple sclerosis|
RA Bermel, R Bakshi
The Lancet Neurology 5 (2), 158-170, 2006
|T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study|
R Bakshi, RHB Benedict, RA Bermel, SD Caruthers, SR Puli, CW Tjoa, ...
Archives of neurology 59 (1), 62-68, 2002
|Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis|
A Petzold, LJ Balcer, PA Calabresi, F Costello, TC Frohman, EM Frohman, ...
The Lancet Neurology 16 (10), 797-812, 2017
|Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study|
EH Martinez-Lapiscina, S Arnow, JA Wilson, S Saidha, JL Preiningerova, ...
The Lancet Neurology 15 (6), 574-584, 2016
|Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis|
RA Bermel, R Bakshi, C Tjoa, SR Puli, L Jacobs
Archives of neurology 59 (2), 275-280, 2002
|Predictors of long‐term outcome in multiple sclerosis patients treated with interferon beta|
RA Bermel, X You, P Foulds, R Hyde, JH Simon, E Fisher, RA Rudick
Annals of neurology 73 (1), 95-103, 2013
|A semiautomated measure of whole-brain atrophy in multiple sclerosis|
RA Bermel, J Sharma, CW Tjoa, SR Puli, R Bakshi
Journal of the neurological sciences 208 (1-2), 57-65, 2003
|Regional brain atrophy is associated with physical disability in multiple sclerosis: semiquantitative magnetic resonance imaging and relationship to clinical findings|
R Bakshi, RHB Benedict, RA Bermel, L Jacobs
Journal of Neuroimaging 11 (2), 129-136, 2001
|Phase 2 trial of ibudilast in progressive multiple sclerosis|
RJ Fox, CS Coffey, R Conwit, ME Cudkowicz, T Gleason, A Goodman, ...
New England Journal of Medicine 379 (9), 846-855, 2018
|Selective caudate atrophy in multiple sclerosis: a 3D MRI parcellation study|
RA Bermel, MD Innus, CW Tjoa, R Bakshi
Neuroreport 14 (3), 335-339, 2003
|Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis|
R Bakshi, VSR Dandamudi, M Neema, C De, RA Bermel
Journal of Neuroimaging 15, 30S-45S, 2005
|Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity|
RA Bermel, SR Puli, RA Rudick, B Weinstock-Guttman, E Fisher, ...
Archives of neurology 62 (9), 1371-1376, 2005
|Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study|
RA Bermel, B Weinstock-Guttman, D Bourdette, P Foulds, X You, ...
Multiple Sclerosis Journal 16 (5), 588-596, 2010
|Interferon-β treatment for multiple sclerosis|
RA Bermel, RA Rudick
Neurotherapeutics 4 (4), 633-646, 2007
|Retinal nerve fiber layer thinning in Alzheimer’s disease: a case–control study in comparison to normal aging, Parkinson’s disease, and non-Alzheimer’s dementia|
JA Pillai, R Bermel, A Bonner-Jackson, A Rae-Grant, H Fernandez, ...
American Journal of Alzheimer's Disease & Other Dementias® 31 (5), 430-436, 2016
|Hippocampal volume is related to cognitive decline and fornicial diffusion measures in multiple sclerosis|
KA Koenig, KE Sakaie, MJ Lowe, J Lin, L Stone, RA Bermel, EB Beall, ...
Magnetic resonance imaging 32 (4), 354-358, 2014
|Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis|
JA Cohen, PB Imrey, SM Planchon, RA Bermel, E Fisher, RJ Fox, ...
Multiple Sclerosis Journal 24 (4), 501-511, 2018
|Processing speed test: Validation of a self-administered, iPad®-based tool for screening cognitive dysfunction in a clinic setting|
SM Rao, G Losinski, L Mourany, D Schindler, B Mamone, C Reece, ...
Multiple Sclerosis Journal 23 (14), 1929-1937, 2017
|Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis|
RJ Fox, CS Coffey, ME Cudkowicz, T Gleason, A Goodman, EC Klawiter, ...
Contemporary clinical trials 50, 166-177, 2016
|Early tolerability and safety of fingolimod in clinical practice|
D Ontaneda, C Hara-Cleaver, RA Rudick, JA Cohen, RA Bermel
Journal of the neurological sciences 323 (1-2), 167-172, 2012